Alexander S. McLawhorn, Sang Jo Kim, Jacques T. YaDeau, Christopher L. Wu, Rosemary Hogg, George Go, Ellen M. Soffin, Janis Bekeris, Carlos B. Mantilla, Sandra L. Kopp, Paul Kessler, Peter Gerner, Rebecca L. Johnson, Jiabin Liu, Douglas S Wetmore, Jashvant Poeran, Philip Peng, Rie Goto, Eriphili Argyra, Mary J. Hargett, Pamela Wendel, Nigel E. Sharrock, Crispiana Cozowicz, Patricia Lavand'homme, Lila Baaklini, Effrossyni Gina Votta-Velis, Lazaros Poultsides, Eric C. Sun, Javad Parvizi, Eric S. Schwenk, Lukas Pichler, Michael John Barrington, Catherine H. MacLean, Alain Borgeat, Jose De Andres, Alejandro Gonzalez Della Valle, Stavros G. Memtsoudis, Kariem El-Boghdadly, Nabil M. Elkassabany, Eugene R. Viscusi, Ottokar Stundner, Henrik Kehlet, Philippe Gautier, Bradley H. Lee, Genewoo Hong, Michael L. Parks, Enrique A. Goytizolo, Brian D. Sites, Dan McIsaac, Dace Bekere, Vassilis Athanassoglou, Edward R. Mariano, Joseph M. Neal, Zhenggang Guo, Alan J. R. Macfarlane, Bridget Jivanelli, and Mark Brouillette more...
BackgroundEvidence-based international expert consensus regarding the impact of peripheral nerve block (PNB) use in total hip/knee arthroplasty surgery.MethodsA systematic review and meta-analysis: randomized controlled and observational studies investigating the impact of PNB utilization on major complications, including mortality, cardiac, pulmonary, gastrointestinal, renal, thromboembolic, neurologic, infectious, and bleeding complications.Medline, PubMed, Embase, and Cochrane Library including Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, were queried from 1946 to August 4, 2020.The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess evidence quality and for the development of recommendations.ResultsAnalysis of 122 studies revealed that PNB use (compared with no use) was associated with lower ORs for (OR with 95% CIs) for numerous complications (total hip and knee arthroplasties (THA/TKA), respectively): cognitive dysfunction (OR 0.30, 95% CI 0.17 to 0.53/OR 0.52, 95% CI 0.34 to 0.80), respiratory failure (OR 0.36, 95% CI 0.17 to 0.74/OR 0.37, 95% CI 0.18 to 0.75), cardiac complications (OR 0.84, 95% CI 0.76 to 0.93/OR 0.83, 95% CI 0.79 to 0.86), surgical site infections (OR 0.55 95% CI 0.47 to 0.64/OR 0.86 95% CI 0.80 to 0.91), thromboembolism (OR 0.74, 95% CI 0.58 to 0.96/OR 0.90, 95% CI 0.84 to 0.96) and blood transfusion (OR 0.84, 95% CI 0.83 to 0.86/OR 0.91, 95% CI 0.90 to 0.92).ConclusionsBased on the current body of evidence, the consensus group recommends PNB use in THA/TKA for improved outcomes.Recommendation: PNB use is recommended for patients undergoing THA and TKA except when contraindications preclude their use. Furthermore, the alignment of provider skills and practice location resources needs to be ensured. Evidence level: moderate; recommendation: strong. more...